Claire Keating

Learn More
BACKGROUND Gastro esophageal reflux (GER) is common in cystic fibrosis (CF) and may contribute to lung disease. Approximately 50% of patients with cystic fibrosis are being treated with proton pump inhibitors (PPIs). METHODS In a randomized controlled study in adults, we compared treatment with esomeprazole 40 mg twice daily versus placebo in patients(More)
  • 1